Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial

(Resolution 466/12 CNS, 2012) and was approved by the Ethics Committee of the Tropical Medicine Foundation Dr. Heitor Vieira Dourado (CAAE 80862417.3.0000.0005). Ministry of Health of Brazil.

Detalles Bibliográficos
Autores: Mendes, Luciana, Guerra, Jorge Oliveira, Costa, Bleno, Silva, Aríneia Soares da, Guerra, Maria das Graças Barbosa, Ortiza, Jéssica, Doria, Susan Smith, Silva, George Villarouco da, Jesus, Denison Vital de, Barral Netto, Manoel, Penna, Gerson, Carvalho, Edgar Marcelino de, Machado, Paulo R.l.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:Brasil
Institución:Fundação Oswaldo Cruz (FIOCRUZ)
Repositorio:Repositório Institucional da FIOCRUZ (ARCA)
Idioma:inglés
OAI Identifier:oai:arca.fiocruz.br:icict/45981
Acceso en línea:https://arca.fiocruz.br/handle/icict/45981
Access Level:acceso abierto
Palabra clave:Leishmaniose cutânea
Fator Estimulador de Colônias de Granulócitos e Macrófagos
Antimoniato de meglumina
Leishmania guyanensis
Cutaneous leishmaniasis
GM-CSF
Miltefosine
Meglumine antimoniate
Descripción
Sumario:(Resolution 466/12 CNS, 2012) and was approved by the Ethics Committee of the Tropical Medicine Foundation Dr. Heitor Vieira Dourado (CAAE 80862417.3.0000.0005). Ministry of Health of Brazil.

Similares en LA Referencia